Dr Jerome Canady, MD | |
106 Irving St Nw, Suite 406, Washington, DC 20010-2927 | |
(202) 877-0532 | |
(412) 877-9088 |
Full Name | Dr Jerome Canady |
---|---|
Gender | Male |
Speciality | Transplant Surgery |
Location | 106 Irving St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467504415 | NPI | - | NPPES |
101963446002 | Medicaid | PA |
Entity Name | Canady Surgical Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558663468 PECOS PAC ID: 9032392675 Enrollment ID: O20110321000139 |
News Archive
A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.
Thirty years into the HIV epidemic, many people who are at high risk of HIV infection cannot or will not adopt safer sexual practices, such as abstinence and condom use. This means there is room in the market for alternative methods to reduce either exposure to or transmission of HIV among these individuals.
Kessler Foundation scientists have published a study showing that use of a foot drop stimulator during a task-specific movement for 4 weeks can retrain the neuromuscular system. This finding indicates that applying the foot drop stimulator as rehabilitation intervention may facilitate recovery from this common complication of stroke.
In Nebraska, a Republican Senate candidate opposing the health law once consulted for firms trying to implement it.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jerome Canady, MD 106 Irving St Nw, Suite 406, Washington, DC 20010-2927 Ph: (202) 877-0532 | Dr Jerome Canady, MD 106 Irving St Nw, Suite 406, Washington, DC 20010-2927 Ph: (202) 877-0532 |
News Archive
A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.
Thirty years into the HIV epidemic, many people who are at high risk of HIV infection cannot or will not adopt safer sexual practices, such as abstinence and condom use. This means there is room in the market for alternative methods to reduce either exposure to or transmission of HIV among these individuals.
Kessler Foundation scientists have published a study showing that use of a foot drop stimulator during a task-specific movement for 4 weeks can retrain the neuromuscular system. This finding indicates that applying the foot drop stimulator as rehabilitation intervention may facilitate recovery from this common complication of stroke.
In Nebraska, a Republican Senate candidate opposing the health law once consulted for firms trying to implement it.
› Verified 4 days ago